Ravish Sachar, MD

Cameron Haery, MD
Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Ravish Sachar, MD
Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Stephen G. Ellis, MD
Director, Sones Catheterization Laboratories, Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Address: Stephen G. Ellis, MD, Director, Sones Catheterization Laboratories, F25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail elliss@ccf.org

Dr. Ellis has indicated that he has received grant or research support from the Cordis and Medtronic corporations and serves as a consultant for the Cordis, Boston Scientific, and Guidant corporations.

This paper discusses therapies that are experimental or that are not approved by the US Food and Drug Administration for the use under discussion.

Cameron Haery, MD
Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Ravish Sachar, MD
Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Stephen G. Ellis, MD
Director, Sones Catheterization Laboratories, Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Address: Stephen G. Ellis, MD, Director, Sones Catheterization Laboratories, F25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail elliss@ccf.org

Dr. Ellis has indicated that he has received grant or research support from the Cordis and Medtronic corporations and serves as a consultant for the Cordis, Boston Scientific, and Guidant corporations.

This paper discusses therapies that are experimental or that are not approved by the US Food and Drug Administration for the use under discussion.

Cameron Haery, MD
Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Ravish Sachar, MD
Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Stephen G. Ellis, MD
Director, Sones Catheterization Laboratories, Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Address: Stephen G. Ellis, MD, Director, Sones Catheterization Laboratories, F25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail elliss@ccf.org

Dr. Ellis has indicated that he has received grant or research support from the Cordis and Medtronic corporations and serves as a consultant for the Cordis, Boston Scientific, and Guidant corporations.

This paper discusses therapies that are experimental or that are not approved by the US Food and Drug Administration for the use under discussion.